2014 Symposium

Inaugural Immuno-Hematology Symposium

Keynote Speaker: Dr. Steve Holland

CHIEF, LABORATORY OF INFECTIOUS DISEASES AND IMMUNOPATHOGENESIS SECTION AT THE NIAID
 
FRIDAY, FEBRURAY 28TH, 2014
KAHN AUDITORIUM, BSRB

We would like to express a heartfelt THANK YOU for all the support we received at our Inaugural Immuno-Hematology Symposium! It was a huge success and we look forward to many more exciting events in the future. Please browse the videos of our inspring talks below!

UPDATE: We are thrilled to announce that our second annual 2015 Immuno-Hematology Sympoisum (date TBD) will be keynoted by Dr. Troy Torgerson, attending physician at Seattle Childrens Hospital and assistant professor in the Department of Pediatrics at the University of Washington School of Medicine. He is co-director of the Immunology Diagnostic Laboratory within the Center for Immunity and Immunotherapies at Seattle Childrens Research Institute. Dr. Torgerson's research in the primary immune deficiency communit is well regarded and his address will be a great addition to our second symposium

Introduction:

- Dr. Kelly Walkovich, Director of the Immuno-Hematology Comprehensive Program

 

 

Neutropenia:

Patient Presentation: Living with Neutropenia

- Dr. Holly Miller on behalf of Dr. Kristin Hayes

Shining Light on the Approach to Neutropenia

- Dr. Laurence Boxer

 

 

Bone Marrow Failure and Transplantation:

From Oman to Ann Arbor; Dyskeratosis Congenita in the Modern Era of Therapy

- Dr. Jim Connelly

Telomerase and Shelterine Defects in Bone Marrow Failure Syndromes

- Dr. Ivan Maillard

Delta-Like Notch Ligands Expressed by Host Non-Hematopoietic Radioresistant Cells Regulate Graft-Versus-Host Disease

- Dr. Christen Ebens

Fatty Acid Metabolism Provides a Potential Therapeutic Target to Treat Graft-Versus-Host Disease

- Dr. Craig Byersdorfer

 

 

Lymphoproliferation:

Recurrent Fevers and Self-Reseolving Cytopenias in an Infant with XIAP Deficiency

- Dr. Miriam Bornhorst

Regulation of HIF-1alpha by XIAP-Mediated Ubiquitination (NOT AVAILABLE)

- Dr. Niall Kenneth

Can we translate our Knowledge of the cellular roles of SAP and XIAP into new treatment modalities for XLP disease? (NOT AVAILABLE)

- Dr. Colin Duckett 

 

Primary Immune Deficiency

Patient Presentation: Impact of an Abnormal Newborn TREC Assay

- Ashley Shaver, MD Candidate

- Allison Hopper, Parent

Functional Characterization of a Hypomorphic Artemis Mutation Associated with Immunodeficiency and Lymphoma (NOT AVAILABLE)

- Dr. JoAnn Sekiguchi

 

Best Abstract

Glioma-Derived Galectin-1 is a Potent Suppressor of NK Immunosurveillence

- Gregory Baker, PhD Candidate

 

 

Keynote Speaker

Leukocytes, Leukemia and Lymphatics: This has GATA2 Be Good

- Dr. Steven Holland